US5744327A
(en)
*
|
1990-02-20 |
1998-04-28 |
Board Of Regents, The University Of Texas System |
Methods for producing insulin in response to non-glucose secretagogues
|
US5427940A
(en)
*
|
1991-06-03 |
1995-06-27 |
Board Of Regents, The University Of Texas System |
Engineered cells producing insulin in response to glucose
|
US5792656A
(en)
*
|
1991-06-03 |
1998-08-11 |
Board Of Regents, The University Of Texas System |
Methods of preparing genetically engineered cells that produce insulin in response to glucose
|
US5571787A
(en)
|
1993-07-30 |
1996-11-05 |
Myelos Corporation |
Prosaposin as a neurotrophic factor
|
US5908623A
(en)
*
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
ES2178654T3
(es)
*
|
1993-08-12 |
2003-01-01 |
Neurotech Sa |
Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas.
|
US5550050A
(en)
|
1994-04-15 |
1996-08-27 |
Cytotherapeutics, Inc. |
Method for implanting encapsulated cells in a host
|
US5670347A
(en)
|
1994-05-11 |
1997-09-23 |
Amba Biosciences Llc |
Peptide-mediated gene transfer
|
US5858747A
(en)
*
|
1994-07-20 |
1999-01-12 |
Cytotherapeutics, Inc. |
Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers
|
AU721869B2
(en)
*
|
1995-05-12 |
2000-07-13 |
Brigham And Women's Hospital |
Treatment of alzheimer disease by modulation of synapsins
|
IN181898B
(es)
*
|
1995-06-07 |
1998-10-24 |
Cytotherapeutics Inc |
|
US7279313B2
(en)
*
|
1995-09-15 |
2007-10-09 |
Centelion |
Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
|
US7364894B2
(en)
*
|
1995-09-15 |
2008-04-29 |
Centelion |
Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
|
FR2738842B1
(fr)
*
|
1995-09-15 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
WO1997012635A1
(en)
*
|
1995-10-02 |
1997-04-10 |
Cytotherapeutics, Inc. |
Method for treating amyotrophic lateral sclerosis
|
US5855613A
(en)
|
1995-10-13 |
1999-01-05 |
Islet Sheet Medical, Inc. |
Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
|
US5837681A
(en)
*
|
1996-02-23 |
1998-11-17 |
Amgen Inc. |
Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US5929041A
(en)
*
|
1996-02-23 |
1999-07-27 |
Amgen Inc. |
Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US7297331B2
(en)
*
|
1996-04-03 |
2007-11-20 |
The Rogosin Institute |
Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
|
US6224912B1
(en)
*
|
1996-04-03 |
2001-05-01 |
The Rogo Institute |
Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
|
US6210664B1
(en)
*
|
1996-04-08 |
2001-04-03 |
New York University Medical Center |
Method for gene transfer to the central nervous system
|
AU2674097A
(en)
*
|
1996-04-17 |
1997-11-07 |
Cytotherapeutics, Inc. |
Method and device for delivery of apoptosis-inducing molecules
|
US7138251B1
(en)
|
1996-04-22 |
2006-11-21 |
Amgen Inc. |
Polynucleotides encoding a neurotrophic factor receptor
|
US6027721A
(en)
*
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
US6054142A
(en)
*
|
1996-08-01 |
2000-04-25 |
Cyto Therapeutics, Inc. |
Biocompatible devices with foam scaffolds
|
US6150164A
(en)
*
|
1996-09-30 |
2000-11-21 |
The Regents Of The University Of Michigan |
Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
|
US6593290B1
(en)
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US6156728A
(en)
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
AU718500B2
(en)
*
|
1997-01-23 |
2000-04-13 |
Sumitomo Pharmaceuticals Company, Limited |
Remedies for diabetes
|
US5844077A
(en)
*
|
1997-04-28 |
1998-12-01 |
Cytotherapeutics, Inc. |
Use of conantokins for producing analgesia or for neuroprotection
|
US6042579A
(en)
*
|
1997-04-30 |
2000-03-28 |
Medtronic, Inc. |
Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
|
JP2002505576A
(ja)
*
|
1997-05-30 |
2002-02-19 |
アムジエン・インコーポレーテツド |
神経栄養因子レセプター
|
US6254865B1
(en)
|
1997-06-17 |
2001-07-03 |
University Technology Corporation |
Method of treating huntington's disease using HNT neurons
|
AU8180498A
(en)
*
|
1997-06-30 |
1999-01-19 |
Regents Of The University Of California, The |
Method for treatment of spinal cord injuries in a mammal
|
US6121415A
(en)
|
1997-07-09 |
2000-09-19 |
Genentech, Inc. |
ErbB4 receptor-specific neuregolin related ligands and uses therefor
|
ZA986077B
(en)
|
1997-07-09 |
2000-01-10 |
Genentech Inc |
ErbB4 receptor-specific neuregulin related ligands and uses therefor.
|
US6071748A
(en)
|
1997-07-16 |
2000-06-06 |
Ljl Biosystems, Inc. |
Light detection device
|
US6469311B1
(en)
|
1997-07-16 |
2002-10-22 |
Molecular Devices Corporation |
Detection device for light transmitted from a sensed volume
|
US6994856B1
(en)
|
1997-07-24 |
2006-02-07 |
Genentech, Inc. |
ErbB4 receptor-specific neuregulin related ligands and uses therefor
|
US6043221A
(en)
*
|
1997-07-30 |
2000-03-28 |
Amgen Inc. |
Method for preventing and treating hearing loss using a neuturin protein product
|
US6042909A
(en)
*
|
1997-09-03 |
2000-03-28 |
Circe Biomedical, Inc. |
Encapsulation device
|
US7745142B2
(en)
|
1997-09-15 |
2010-06-29 |
Molecular Devices Corporation |
Molecular modification assays
|
US6297018B1
(en)
|
1998-04-17 |
2001-10-02 |
Ljl Biosystems, Inc. |
Methods and apparatus for detecting nucleic acid polymorphisms
|
US6576476B1
(en)
|
1998-09-02 |
2003-06-10 |
Ljl Biosystems, Inc. |
Chemiluminescence detection method and device
|
US6326605B1
(en)
|
1998-02-20 |
2001-12-04 |
Ljl Biosystems, Inc. |
Broad range light detection system
|
WO2000006990A2
(en)
|
1998-07-27 |
2000-02-10 |
Ljl Biosystems, Inc. |
Apparatus and methods for time-resolved spectroscopic measurements
|
US6825921B1
(en)
|
1999-11-10 |
2004-11-30 |
Molecular Devices Corporation |
Multi-mode light detection system
|
WO2000050877A1
(en)
|
1999-02-23 |
2000-08-31 |
Ljl Biosystems, Inc. |
Frequency-domain light detection device
|
US6156729A
(en)
*
|
1997-10-15 |
2000-12-05 |
California Institute Of Technology |
Leukemia inhibitory factor for use in modulating inflammation and pain
|
US6485901B1
(en)
*
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
CA2245224A1
(en)
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
CA2305787A1
(en)
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
AU762472B2
(en)
|
1998-03-13 |
2003-06-26 |
University Of British Columbia, The |
Therapeutic chemokine receptor antagonists
|
US6277820B1
(en)
|
1998-04-09 |
2001-08-21 |
Genentech, Inc. |
Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells
|
US6303136B1
(en)
|
1998-04-13 |
2001-10-16 |
Neurotech S.A. |
Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
|
WO1999057248A1
(en)
*
|
1998-04-30 |
1999-11-11 |
President And Fellows Of Harvard College |
Induction of neuronal regeneration
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
AU4981999A
(en)
*
|
1998-07-24 |
2000-02-14 |
Allegheny University Of The Health Sciences |
Allogeneic cellular immunogens useful as cancer vaccines
|
AU5223899A
(en)
|
1998-07-27 |
2000-02-21 |
Ljl Biosystems, Inc. |
Apparatus and methods for spectroscopic measurements
|
US20020115213A1
(en)
*
|
1998-08-14 |
2002-08-22 |
Northeastern Ohio Universities Of Medicine |
Engraftable neural progenitor & stem cells for brain tumor therapy
|
AU6141599A
(en)
*
|
1998-09-09 |
2000-03-27 |
Myelos Corporation |
Method of stimulating prosaposin receptor activity
|
IL141865A0
(en)
*
|
1998-09-09 |
2002-03-10 |
Myelos Corp |
Method of stimulating prosaposin receptor activity
|
US6344541B1
(en)
*
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
US6156514A
(en)
*
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
US6303749B1
(en)
|
1999-01-29 |
2001-10-16 |
Amgen Inc. |
Agouti and agouti-related peptide analogs
|
US7708993B2
(en)
*
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
HUP0105337A3
(en)
*
|
1999-02-03 |
2011-01-28 |
Amgen Inc |
Polypeptides involved in immune response
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
US6713293B1
(en)
*
|
1999-02-08 |
2004-03-30 |
Friedrich Grummt |
Encapsulated cells containing an amplified expression vector as a drug delivery device
|
JP4812167B2
(ja)
*
|
1999-02-12 |
2011-11-09 |
モレキュラー インサイト ファーマスーティカルズ インコーポレイテッド |
薬物輸送用マトリックス、ならびにその作成方法および使用方法
|
US6903244B1
(en)
|
1999-02-26 |
2005-06-07 |
University Of Utah Research Foundation |
Mice which are +/− or −/− for the elastin gene as models for vascular disease
|
US6303355B1
(en)
|
1999-03-22 |
2001-10-16 |
Duke University |
Method of culturing, cryopreserving and encapsulating pancreatic islet cells
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6365385B1
(en)
|
1999-03-22 |
2002-04-02 |
Duke University |
Methods of culturing and encapsulating pancreatic islet cells
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
AU3770800A
(en)
|
1999-03-26 |
2000-10-16 |
Amgen, Inc. |
Beta secretase genes and polypeptides
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
US20070071734A1
(en)
*
|
1999-04-06 |
2007-03-29 |
Weng Tao |
ARPE-19 as platform cell line for encapsulated cell-based delivery
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US8147824B2
(en)
|
1999-08-05 |
2012-04-03 |
Athersys, Inc. |
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
|
WO2001011011A2
(en)
|
1999-08-05 |
2001-02-15 |
Mcl Llc |
Multipotent adult stem cells and methods for isolation
|
US7408047B1
(en)
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US6878543B1
(en)
|
1999-10-25 |
2005-04-12 |
Nsgene Sa |
Cultures of GFAP+ nestin+ cells that differentiate to neurons
|
US6267954B1
(en)
|
1999-11-24 |
2001-07-31 |
Universite De Paris V Rene-Descartes |
Intraocular transplantation of encapsulated cells
|
US7060676B2
(en)
*
|
1999-12-20 |
2006-06-13 |
Trustees Of Tufts College |
T. cruzi-derived neurotrophic agents and methods of use therefor
|
US6458118B1
(en)
|
2000-02-23 |
2002-10-01 |
Medtronic, Inc. |
Drug delivery through microencapsulation
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US20050059584A1
(en)
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
US7368425B2
(en)
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
US7378098B2
(en)
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
AU7161801A
(en)
*
|
2000-06-28 |
2002-01-08 |
Amgen Inc |
B7-like molecules and uses thereof
|
JP2004519205A
(ja)
|
2000-06-28 |
2004-07-02 |
アムジェン インコーポレイテッド |
胸腺間質リンホポイエチンレセプター分子およびその使用
|
US6538010B1
(en)
*
|
2000-11-08 |
2003-03-25 |
Research Triangle Institute |
Compounds and methods for promoting smoking cessation
|
JP4236925B2
(ja)
|
2000-11-28 |
2009-03-11 |
アムジエン・インコーポレーテツド |
免疫応答に関与する新規ポリペプチド
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US7276580B2
(en)
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
ATE411001T1
(de)
*
|
2001-05-11 |
2008-10-15 |
Ortho Mcneil Janssen Pharm |
Immunmodulations-vorrichtung zur verwendung in tieren
|
JP2004530436A
(ja)
*
|
2001-06-22 |
2004-10-07 |
ユニべルシテ・カトリック・ドゥ・ルベン |
昆虫の産卵および内部捕食寄生生物の飼養のための人工培地としてのヒドロゲルビーズまたはカプセル
|
EP1281767A3
(en)
|
2001-07-31 |
2003-05-28 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of tumors
|
US7332330B2
(en)
|
2001-09-11 |
2008-02-19 |
Renamed Biologics, Inc. |
Device for maintaining vascularization near an implant
|
US7981863B2
(en)
*
|
2001-09-19 |
2011-07-19 |
Neuronova Ab |
Treatment of Parkinson's disease with PDGF
|
DE10164039A1
(de)
*
|
2001-12-28 |
2003-07-10 |
Nmi Univ Tuebingen |
Implantierbare Vorrichtung und deren Verwendung
|
US7662924B2
(en)
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US7442546B2
(en)
*
|
2002-03-15 |
2008-10-28 |
The Regents Of The University Of Michigan |
Method of modulating inflammatory response
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
PT1458853E
(pt)
|
2002-05-16 |
2010-02-23 |
Absorber Ab |
Processos de prova directa de compatibilidade específicos para dadores
|
US20030228261A1
(en)
*
|
2002-06-05 |
2003-12-11 |
Aladar Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
EP1369491A1
(en)
*
|
2002-06-05 |
2003-12-10 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
DK2213730T3
(en)
*
|
2002-06-18 |
2016-01-25 |
Eisai R&D Man Co Ltd |
Primary cultured adipocytes for gene therapy
|
US7369894B2
(en)
*
|
2002-09-06 |
2008-05-06 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
|
US7328069B2
(en)
*
|
2002-09-06 |
2008-02-05 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
|
US7276057B2
(en)
*
|
2002-09-06 |
2007-10-02 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
|
US7328068B2
(en)
*
|
2003-03-31 |
2008-02-05 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
|
US7427280B2
(en)
|
2002-09-06 |
2008-09-23 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US7618948B2
(en)
*
|
2002-11-26 |
2009-11-17 |
Medtronic, Inc. |
Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
|
US7605249B2
(en)
*
|
2002-11-26 |
2009-10-20 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
AU2002952993A0
(en)
|
2002-11-29 |
2002-12-12 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
Therapeutic and diagnostic agents
|
US20040230182A1
(en)
*
|
2002-12-27 |
2004-11-18 |
Medtronic, Inc. |
Drug delivery through encapsulation
|
US7732591B2
(en)
*
|
2003-11-25 |
2010-06-08 |
Medtronic, Inc. |
Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
|
US7994149B2
(en)
|
2003-02-03 |
2011-08-09 |
Medtronic, Inc. |
Method for treatment of Huntington's disease through intracranial delivery of sirna
|
CA2522364C
(en)
|
2003-04-18 |
2014-12-09 |
Biogen Idec Ma Inc. |
Polymer-conjugated glycosylated neublastin
|
US7459152B2
(en)
*
|
2003-04-23 |
2008-12-02 |
Rush University Medical Center |
Erythropoietin administration to improve graft survival
|
DK1624936T3
(da)
|
2003-05-16 |
2010-03-15 |
Univ Laval |
CNS-chloridmodulering og anvendelser deraf
|
ES2323066T3
(es)
|
2003-06-10 |
2009-07-06 |
Nsgene A/S |
Secrecion mejorada de neublastina.
|
CN100562570C
(zh)
|
2003-06-18 |
2009-11-25 |
吉恩勒克斯公司 |
修饰的重组痘苗病毒及其它微生物,及其应用
|
WO2005020677A1
(en)
|
2003-08-29 |
2005-03-10 |
The Walter And Eliza Hall Institute Of Medical Research |
Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening
|
AU2004283053A1
(en)
|
2003-10-20 |
2005-05-06 |
Nsgene A/S |
In vivo gene therapy of Parkinson's Disease
|
CA2551189A1
(en)
|
2003-12-24 |
2005-07-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Therapeutic agents and uses therefor
|
WO2005068498A2
(en)
*
|
2004-01-19 |
2005-07-28 |
Nsgene A/S |
Human therapeutic cells secreting nerve growth factor
|
US8467875B2
(en)
|
2004-02-12 |
2013-06-18 |
Medtronic, Inc. |
Stimulation of dorsal genital nerves to treat urologic dysfunctions
|
US20050208090A1
(en)
*
|
2004-03-18 |
2005-09-22 |
Medtronic, Inc. |
Methods and systems for treatment of neurological diseases of the central nervous system
|
DE602005014354D1
(de)
|
2004-03-30 |
2009-06-18 |
Nsgene As |
Therapeutische verwendung des wachstumsfaktors nsg33
|
US8741635B2
(en)
|
2004-05-12 |
2014-06-03 |
The Walter And Eliza Hall Institute Of Medical Research |
Method of cell isolation
|
US8309070B2
(en)
|
2004-05-17 |
2012-11-13 |
Regents Of The University Of Minnesota |
Use of umbilical cord blood stem cells to treat ischemic event
|
WO2006013462A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Nsgene A/S |
Growth factors nsg28, nsg30, and nsg32
|
CA2577755C
(en)
|
2004-08-19 |
2014-05-13 |
Biogen Idec Ma Inc. |
Neublastin variants
|
CN101123978B
(zh)
|
2004-08-19 |
2012-12-12 |
比奥根艾迪克Ma公司 |
神经胚素变体
|
US20060099193A1
(en)
*
|
2004-10-22 |
2006-05-11 |
Ikuko Sugaya |
Methods and materials for suppressing pain
|
MX2007012155A
(es)
|
2005-04-01 |
2008-04-04 |
Nsgene As |
Linea celular precursora neural inmortalizada humana.
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
KR101504622B1
(ko)
|
2005-04-29 |
2015-03-20 |
에이전시 포 사이언스, 테크놀로지 앤드 리서치 |
고차가지구조 고분자 및 그들의 응용
|
US20060257368A1
(en)
*
|
2005-05-03 |
2006-11-16 |
Clemson University |
Devices and methods for improved viability of cells
|
US20090022785A1
(en)
*
|
2005-05-03 |
2009-01-22 |
Veterinarmedizinische Universitat Wien |
Permeable Capsules
|
EP1885854B1
(en)
*
|
2005-05-06 |
2012-10-17 |
Medtronic, Inc. |
Methods and sequences to suppress primate huntington gene expression
|
US7902352B2
(en)
*
|
2005-05-06 |
2011-03-08 |
Medtronic, Inc. |
Isolated nucleic acid duplex for reducing huntington gene expression
|
AU2006246826B2
(en)
|
2005-05-17 |
2011-01-06 |
Gloriana Therapeutics Sarl |
An implantable therapy system for treating a living being with an active factor
|
US20090169523A1
(en)
|
2005-06-13 |
2009-07-02 |
Catherine Verfaillie |
Hsc self-renewal
|
AU2006261599B2
(en)
|
2005-06-24 |
2011-10-06 |
The Walter & Eliza Hall Institute Of Medical Research |
Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same
|
US9133517B2
(en)
*
|
2005-06-28 |
2015-09-15 |
Medtronics, Inc. |
Methods and sequences to preferentially suppress expression of mutated huntingtin
|
US20080280843A1
(en)
*
|
2006-05-24 |
2008-11-13 |
Van Bilsen Paul |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
US8357666B2
(en)
|
2005-08-01 |
2013-01-22 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through RNA interference
|
DK1919954T3
(en)
|
2005-08-30 |
2017-01-30 |
Univ Miami |
Immune modulating tumor necrosis factor receptor (TNFR25) - agonists, antagonists and immunotoxins
|
US9388382B2
(en)
*
|
2005-10-05 |
2016-07-12 |
The Board Of Trustees Of The University Of Illinois |
Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
|
JP2009513584A
(ja)
*
|
2005-10-28 |
2009-04-02 |
エヌエスゲーネ・アクティーゼルスカブ |
Gdnfの送達のための移植可能な生体適合性免疫隔離ビヒクル
|
US10117900B2
(en)
*
|
2005-11-09 |
2018-11-06 |
Athersys, Inc. |
MAPC treatment of brain injuries and diseases
|
US11000546B2
(en)
|
2005-11-09 |
2021-05-11 |
Athersys, Inc. |
Immunomodulatory properties of MAPCs and uses thereof
|
MY147669A
(en)
|
2005-11-18 |
2012-12-31 |
Glenmark Pharmaceuticals Sa |
Anti-alpha2 integrin antibodies and their uses
|
ES2406716T3
(es)
|
2005-12-30 |
2013-06-07 |
Neurotech Usa, Inc. |
Dispositivo micronizado para el suministro de moléculas activas biológicamente y método de uso del mismo
|
NZ727755A
(en)
*
|
2006-01-23 |
2023-01-27 |
Abt Holding Co |
Mapc therapeutics without adjunctive immunosuppressive treatment
|
DK1981515T3
(da)
|
2006-01-23 |
2013-07-22 |
Athersys Inc |
MAPC behandling af hjerneskader og -sygdomme
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
EP3712258A1
(en)
|
2006-04-14 |
2020-09-23 |
Astellas Institute for Regenerative Medicine |
Hemangio-colony forming cells
|
US20070255333A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Medtronic, Inc. |
Neuromodulation therapy for perineal or dorsal branch of pudendal nerve
|
US9273356B2
(en)
|
2006-05-24 |
2016-03-01 |
Medtronic, Inc. |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
JP5558817B2
(ja)
|
2006-07-18 |
2014-07-23 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
痛みの処置方法および鎮痛化合物のスクリーニング方法
|
US20080039415A1
(en)
*
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
CA2666789C
(en)
*
|
2006-10-18 |
2016-11-22 |
Yong Zhao |
Embryonic-like stem cells derived from adult human peripheral blood and methods of use
|
US9375440B2
(en)
*
|
2006-11-03 |
2016-06-28 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
US7988668B2
(en)
*
|
2006-11-21 |
2011-08-02 |
Medtronic, Inc. |
Microsyringe for pre-packaged delivery of pharmaceuticals
|
US7819842B2
(en)
*
|
2006-11-21 |
2010-10-26 |
Medtronic, Inc. |
Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites
|
US20080171906A1
(en)
*
|
2007-01-16 |
2008-07-17 |
Everaerts Frank J L |
Tissue performance via hydrolysis and cross-linking
|
US8545834B2
(en)
*
|
2007-03-15 |
2013-10-01 |
The Mclean Hospital Corporation |
G-substrate for the treatment and prevention of parkinson's disease
|
EP2508614A3
(en)
|
2007-04-03 |
2012-11-28 |
Oxyrane UK Limited |
Glycosylation of molecules
|
WO2008137574A1
(en)
|
2007-05-01 |
2008-11-13 |
Biogen Idec Ma Inc. |
Compositions and methods for increasing vascularization
|
EP2185730A4
(en)
|
2007-08-23 |
2010-10-27 |
Intrexon Corp |
METHOD AND COMPOSITIONS FOR SICKNESS DIAGNOSIS
|
WO2009029508A1
(en)
*
|
2007-08-28 |
2009-03-05 |
Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute, Inc. |
Intracranial catheter and methods of use
|
AU2008307643B9
(en)
|
2007-09-28 |
2014-04-17 |
Intrexon Corporation |
Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
|
DK2592148T3
(en)
|
2007-10-12 |
2018-12-10 |
Hoffmann La Roche |
Protein expression from multiple nucleic acids
|
CA2712496C
(en)
|
2008-01-18 |
2021-01-12 |
Wei-Shou Hu |
Stem cell aggregates and methods for making and using
|
US20090196854A1
(en)
*
|
2008-02-04 |
2009-08-06 |
Kytos Biosystems S.A. |
Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
|
WO2009125332A1
(en)
*
|
2008-04-07 |
2009-10-15 |
Peter Bromley |
New and safe procedure for immunization against infectious diseases agents
|
WO2009126250A2
(en)
|
2008-04-07 |
2009-10-15 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through rna interference
|
KR101923290B1
(ko)
|
2008-05-06 |
2018-11-28 |
아스텔라스 인스티튜트 포 리제너러티브 메디슨 |
혈관 콜로니 형성 세포 및 비-생착성 혈관 세포
|
CA2722766A1
(en)
|
2008-05-06 |
2009-11-12 |
Advanced Cell Technology, Inc. |
Methods for producing enucleated erythroid cells derived from pluripotent stem cells
|
US8586558B2
(en)
*
|
2008-05-16 |
2013-11-19 |
The Mclean Hospital Corporation |
RAB3B for treatment and prevention of Parkinson's disease
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
AU2009273600B2
(en)
|
2008-07-24 |
2013-04-18 |
Hoba Therapeutics Aps |
Therapeutic use of a growth factor, METRNL
|
US9446168B2
(en)
|
2010-06-07 |
2016-09-20 |
Beta-O2 Technologies Ltd. |
Multiple-layer immune barrier for donor cells
|
WO2010032242A1
(en)
*
|
2008-09-17 |
2010-03-25 |
Beta O2 Technologies Ltd. |
Optimization of alginate encapsulation of islets for transplantation
|
WO2010042747A2
(en)
|
2008-10-10 |
2010-04-15 |
Amgen Inc. |
Fgf21 mutants and uses thereof
|
EP2379711B8
(en)
|
2008-12-23 |
2017-03-22 |
BOCO Silicon Valley, Inc. |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
US20120021039A1
(en)
|
2009-01-23 |
2012-01-26 |
Nsgene A/S |
Expression of neuropeptides in mammalian cells
|
US8741340B2
(en)
*
|
2009-01-23 |
2014-06-03 |
Nsgene A/S |
Cell lines and their use in encapsulated cell biodelivery
|
WO2010111278A1
(en)
|
2009-03-23 |
2010-09-30 |
The Texas A&M University System |
Compositions of mesenchymal stem cells to regenerate bone
|
JP2012524544A
(ja)
*
|
2009-04-23 |
2012-10-18 |
ニューロテック ユーエスエー, インコーポレイテッド |
プロスタグランジンF2アルファ(PGF2a)を産生する細胞系およびその使用
|
EP2427207B1
(en)
|
2009-05-05 |
2017-08-16 |
Amgen, Inc |
Fgf21 mutants and uses thereof
|
PE20160718A1
(es)
|
2009-05-05 |
2016-08-03 |
Amgen Inc |
Polipeptidos mutantes fgf21
|
BRPI0902039B8
(pt)
|
2009-06-09 |
2021-05-25 |
Anhanguera Educacional Ltda |
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
|
ES2586837T3
(es)
|
2009-08-03 |
2016-10-19 |
University Of Miami |
Método para la expansión in vivo de linfocitos T reguladores
|
WO2011039634A2
(en)
|
2009-09-29 |
2011-04-07 |
Universiteit Gent |
Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
|
JP2013507373A
(ja)
*
|
2009-10-08 |
2013-03-04 |
ニューロテック ユーエスエー, インコーポレイテッド |
被包された細胞ベースの送達系におけるpedfの使用
|
KR20130055555A
(ko)
|
2009-11-19 |
2013-05-28 |
옥시레인 유케이 리미티드 |
효모 스트레인 생성용 포유류 유사 복합 n-글리칸들
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
EP2515864A4
(en)
*
|
2009-12-23 |
2013-09-11 |
Psivida Inc |
DELAYED RELEASE DELIVERY DEVICES
|
AU2011220940C1
(en)
|
2010-02-25 |
2015-04-16 |
Abt Holding Company |
Modulation of angiogenesis
|
IL282662B2
(en)
|
2010-02-25 |
2024-01-01 |
Univ Case Western Reserve |
Modulation of macrophage activation
|
WO2011130417A2
(en)
|
2010-04-15 |
2011-10-20 |
Amgen Inc. |
HUMAN FGF RECEPTOR AND β-KLOTHO BINDING PROTEINS
|
WO2011139688A2
(en)
|
2010-04-28 |
2011-11-10 |
The J. David Gladstone Institutes |
Methods for generating cardiomyocytes
|
SG185526A1
(en)
|
2010-05-12 |
2012-12-28 |
Abt Holding Co |
Modulation of splenocytes in cell therapy
|
US9376664B2
(en)
|
2010-06-14 |
2016-06-28 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
US9475709B2
(en)
|
2010-08-25 |
2016-10-25 |
Lockheed Martin Corporation |
Perforated graphene deionization or desalination
|
JP6131190B2
(ja)
|
2010-09-29 |
2017-05-17 |
オキシレイン ユーケー リミテッド |
リン酸化n−グリカンの脱マンノシル化
|
SG189108A1
(en)
|
2010-09-29 |
2013-05-31 |
Oxyrane Uk Ltd |
Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
|
WO2012041328A1
(en)
|
2010-10-01 |
2012-04-05 |
Nsgene A/S |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
US8815942B2
(en)
|
2010-10-20 |
2014-08-26 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
|
US9078878B2
(en)
|
2010-12-01 |
2015-07-14 |
Alderbio Holdings Llc |
Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
|
US11214610B2
(en)
|
2010-12-01 |
2022-01-04 |
H. Lundbeck A/S |
High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
|
CA2821515A1
(en)
|
2010-12-01 |
2012-06-07 |
Alder Biopharmaceuticals, Inc. |
Anti-ngf compositions and use thereof
|
US9539324B2
(en)
|
2010-12-01 |
2017-01-10 |
Alderbio Holdings, Llc |
Methods of preventing inflammation and treating pain using anti-NGF compositions
|
US9067988B2
(en)
|
2010-12-01 |
2015-06-30 |
Alderbio Holdings Llc |
Methods of preventing or treating pain using anti-NGF antibodies
|
US9884909B2
(en)
|
2010-12-01 |
2018-02-06 |
Alderbio Holdings Llc |
Anti-NGF compositions and use thereof
|
WO2012075184A2
(en)
|
2010-12-02 |
2012-06-07 |
Neurotech Usa, Inc. |
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
|
ES2733211T3
(es)
|
2011-04-15 |
2019-11-28 |
Genelux Corp |
Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
|
TW201542231A
(zh)
|
2011-06-06 |
2015-11-16 |
Kineta One Llc |
以shk為主之醫藥組合物及其製備方法及用途
|
AU2012306810B2
(en)
|
2011-09-05 |
2017-09-28 |
Hoba Therapeutics Aps |
Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain
|
EP2825193B1
(en)
|
2012-03-15 |
2019-11-13 |
Oxyrane UK Limited |
Methods and materials for treatment of pompe's disease
|
US9610546B2
(en)
|
2014-03-12 |
2017-04-04 |
Lockheed Martin Corporation |
Separation membranes formed from perforated graphene and methods for use thereof
|
US9744617B2
(en)
|
2014-01-31 |
2017-08-29 |
Lockheed Martin Corporation |
Methods for perforating multi-layer graphene through ion bombardment
|
US10653824B2
(en)
|
2012-05-25 |
2020-05-19 |
Lockheed Martin Corporation |
Two-dimensional materials and uses thereof
|
US9834809B2
(en)
|
2014-02-28 |
2017-12-05 |
Lockheed Martin Corporation |
Syringe for obtaining nano-sized materials for selective assays and related methods of use
|
WO2013181424A1
(en)
|
2012-05-30 |
2013-12-05 |
Neurotech Usa, Inc. |
Cryopreserved implantable cell culture devices and uses thereof
|
AU2013296611B2
(en)
|
2012-08-01 |
2017-11-23 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
ES2869701T3
(es)
|
2012-08-01 |
2021-10-25 |
United Therapeutics Corp |
Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
|
ES2963968T3
(es)
|
2013-01-09 |
2024-04-03 |
United Therapeutics Corp |
Tratamiento de la vasculopatía con prostaciclina y células madre mesenquimatosas
|
WO2014110258A1
(en)
|
2013-01-09 |
2014-07-17 |
Podack Eckhard R |
Compositions and methods for the regulation of t regulatory cells using tl1a-ig fusion protein
|
WO2014136065A2
(en)
|
2013-03-05 |
2014-09-12 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|
JP6234485B2
(ja)
|
2013-03-07 |
2017-11-22 |
ヴィアサイト インコーポレイテッド |
3次元大収容力細胞封入デバイスアセンブリー
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
WO2014164621A1
(en)
|
2013-03-12 |
2014-10-09 |
Lockheed Martin Corporation |
Method for forming filter with uniform aperture size
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
JOP20140087B1
(ar)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
بروتينات مخصصة ل baff و b7rp1 وإستخداماتها
|
ES2827250T3
(es)
|
2013-04-12 |
2021-05-20 |
Houston Methodist Hospital |
Mejora de órganos para trasplante
|
WO2014184666A2
(en)
|
2013-04-30 |
2014-11-20 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
JP6681826B2
(ja)
|
2013-05-31 |
2020-04-15 |
ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション |
コノトキシンペプチド、医薬組成物およびそれらの使用
|
US9572918B2
(en)
|
2013-06-21 |
2017-02-21 |
Lockheed Martin Corporation |
Graphene-based filter for isolating a substance from blood
|
CA2922483A1
(en)
|
2013-09-11 |
2015-03-19 |
Neurotech Usa, Inc. |
Encapsulated cell therapy cartridge
|
WO2015042580A1
(en)
|
2013-09-23 |
2015-03-26 |
Biogen Idec Ma Inc. |
Compositions and methods for treatment of neuropathic pain
|
JP2017510461A
(ja)
|
2014-01-31 |
2017-04-13 |
ロッキード マーティン コーポレイションLockheed Martin Corporation |
広幅イオン場を用いる二次元材料の穿孔
|
CA2938305A1
(en)
|
2014-01-31 |
2015-08-06 |
Lockheed Martin Corporation |
Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
|
JP2017512129A
(ja)
|
2014-03-12 |
2017-05-18 |
ロッキード・マーチン・コーポレーション |
有孔グラフェンから形成された分離膜
|
AU2015311978A1
(en)
|
2014-09-02 |
2017-05-11 |
Lockheed Martin Corporation |
Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same
|
WO2016036322A1
(en)
*
|
2014-09-04 |
2016-03-10 |
Kemijski inštitut |
Cell-based device for local treatment with therapeutic protein
|
EP3662923A1
(en)
|
2015-05-27 |
2020-06-10 |
Neurotech USA, Inc. |
Use of encapsulated cell therapy for treatment of ophthalmic disorders
|
JP2018528144A
(ja)
|
2015-08-05 |
2018-09-27 |
ロッキード・マーチン・コーポレーション |
グラフェン系材料の穿孔可能なシート
|
AU2016303049A1
(en)
|
2015-08-06 |
2018-03-01 |
Lockheed Martin Corporation |
Nanoparticle modification and perforation of graphene
|
WO2017070738A1
(en)
|
2015-10-27 |
2017-05-04 |
The University Of Queensland |
A method of treatment and agents useful for same
|
JP2019521055A
(ja)
|
2016-04-14 |
2019-07-25 |
ロッキード・マーチン・コーポレーション |
グラフェン欠陥の選択的界面緩和
|
WO2017180134A1
(en)
|
2016-04-14 |
2017-10-19 |
Lockheed Martin Corporation |
Methods for in vivo and in vitro use of graphene and other two-dimensional materials
|
WO2017180135A1
(en)
|
2016-04-14 |
2017-10-19 |
Lockheed Martin Corporation |
Membranes with tunable selectivity
|
CA3020686A1
(en)
|
2016-04-14 |
2017-10-19 |
Lockheed Martin Corporation |
Method for treating graphene sheets for large-scale transfer using free-float method
|
JP2019517909A
(ja)
|
2016-04-14 |
2019-06-27 |
ロッキード・マーチン・コーポレーション |
流路を有する二次元膜構造体
|
EP3443329A4
(en)
|
2016-04-14 |
2020-04-08 |
Lockheed Martin Corporation |
METHODS FOR PROVIDING IN SITU MONITORING AND CONTROL OF DEFECT TRAINING OR HEALING
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
EP3485040B1
(en)
|
2016-07-18 |
2021-04-14 |
ETH Zurich |
B-cell-mimetic cells
|
EP3272877A1
(en)
|
2016-07-18 |
2018-01-24 |
ETH Zurich |
B-cell-mimetic cells
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
US11571444B2
(en)
|
2016-10-24 |
2023-02-07 |
United Therapeutics Corporation |
Enhancement of MSC immunomodulatory properties by treprostinil
|
WO2018089011A1
(en)
|
2016-11-10 |
2018-05-17 |
Viacyte, Inc |
Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof
|
WO2018162517A1
(en)
|
2017-03-10 |
2018-09-13 |
F. Hoffmann-La Roche Ag |
Method for producing multispecific antibodies
|
WO2019050633A2
(en)
|
2017-07-24 |
2019-03-14 |
California Institute Of Technology |
ELECTRICALLY REMOVABLE, CHEMICALLY AMPLIFIED, LOW-POWERED BARRIER
|
EP3656851A1
(en)
|
2018-11-23 |
2020-05-27 |
Technische Universität Dresden |
Artificial hla-positive feeder cell lines for nk cells and uses thereof
|
WO2022011081A1
(en)
|
2020-07-09 |
2022-01-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cell lines that produce human retinoschisin proteins and uses thereof
|
WO2022081760A1
(en)
|
2020-10-14 |
2022-04-21 |
Sana Biotechnology, Inc. |
Hepatocyte-like cells
|
IT202100006569A1
(it)
|
2021-03-18 |
2022-09-18 |
Hemera S R L |
Metodo per ottenere macrofagi rigenerativi educati dal tumore e loro uso nella medicina rigenerativa
|
WO2023081420A1
(en)
|
2021-11-05 |
2023-05-11 |
Abt Holding Company |
Culture-expanded canine progenitor cells and related methods
|
WO2023164171A2
(en)
|
2022-02-25 |
2023-08-31 |
Viacyte, Inc. |
Multilayer implantable cell encapsulation devices and methods thereof
|